• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Lazard US Equity Concentrated Fund C Acc GBP

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider Lazard
Fund Summary The Lazard US Equity Concentrated Fund is an all cap, concentrated fund that seeks long-term capital appreciation. It is benchmark agnostic, seeking to outperform any broad based US index (i.e., S&P 500 Index, Russell 1000 Index, Russell 3000 Index) by investing in financially productive (e.g., high return on equity, free cash flow, cash flow return on investment) companies across the market capitalization spectrum, employing intensive fundamental analysis and accounting validation to identify investment opportunities. The strategy typically invests in 15-35 companies with market capitalizations generally greater than $350 million.
SEDOL code BDC5DB5
ISIN IE00BDC5DB54
Fund code LZUCA
Managers Christopher H. Blake, Martin Flood
Manager Tenure 3 years
Morningstar Category US Large-Cap Blend Equity
IMA Sector North America
Fund Size £251 million
Fund Type OEIC
Management Style Active
Total Expense Ratio (TER) 0.92%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £135.8233
Buy Price £135.8233
Price Change +0.2081%
Price Date 12th July 2019
Yield Currently unavailable
Dividend Frequency Semi-Annually
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 7th December 2016
Fund Status OPEN
Christopher Blake is a Portfolio Manager/Analyst on the US Strategic Equity, US Equity Concentrated and US Mid Cap Equity portfolio teams. He began working in the investment field in 1995 as a Lazard Research Analyst. He has a BSBA in Finance from the University of Denver.

3-year Mean Monthly Return: Currently unavailable

Annual Returns 2018 2017
Fund Performance +16.01% -1.66%
Benchmark Performance
(US Large-Cap Blend Equity)
+16.43% +1.03%
Time Period Cumulative Benchmark Performance
(US Large-Cap Blend Equity)
Fund Compared to Benchmark
1 day 0.21% -0.35% +0.56%
1 week 0.06% +2.39% -2.33%
1 month 6.09% +3.07% +3.02%
3 months 9.35% +6.45% +2.89%
6 months 24.20% +8.51% +15.68%
1 year 16.14% +8.48% +7.66%
3 years Currently unavailable +55.74% Currently unavailable
5 years Currently unavailable +96.12% Currently unavailable
10 years Currently unavailable +285.46% Currently unavailable
YTD 27.16% +16.00% +11.16%
Since inception 35.82% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Medtronic PLC USA 9.62%
Cisco Systems Inc USA 8.10%
Analog Devices Inc USA 6.36%
Coca-Cola Co USA 6.14%
Baxter International Inc USA 5.66%
Armstrong World Industries Inc USA 4.94%
Vulcan Materials Co USA 4.84%
Alphabet Inc A USA 4.77%
Skyworks Solutions Inc USA 4.42%
Intercontinental Exchange Inc USA 4.33%

Currently unavailable